Q2
CV — Q2 2026 Financial Report Analysis
CapsoVision's Q2 2026 revenue rose 10% to $3.6M on 13% more capsules sold, but trial and Canon sensor spending widened the net loss 62% to $7.5M, leaving $9.1M of cash and a going-concern warning before an $18M September share sale.